Article
A new study has joined a host of others concluding that high-volume surgeons have better outcomes than surgeons who perform a procedure less often.
ECLIPSE trial: 177Lu-PSMA-I&T extends rPFS vs hormone therapy in mCRPC
Key updates from the AUA/ASRM male infertility guideline amendment
Collaboration to support phase 3 SECuRE trial of 67Cu-SAR-bisPSMA
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
Variants of unknown significance may adversely affect RARP outcomes
Cretostimogene grenadenorepvec plus nivolumab shows promise in cisplatin-ineligible MIBC